ECOLAB INC. Research and Development Expense
ECOLAB INC. (ECL) reported Research and Development Expense of $202.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-02-23
- ECOLAB INC. research and development expense for fiscal 2025 was $202.00M, a 2.42% decline from fiscal 2024.
- ECOLAB INC. research and development expense for fiscal 2024 was $207.00M, a 7.81% increase from fiscal 2023.
- ECOLAB INC. research and development expense for fiscal 2023 was $192.00M, a 1.05% increase from fiscal 2022.
- ECOLAB INC. research and development expense for fiscal 2022 was $190.00M, a 2.15% increase from fiscal 2021.
| Period end | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $202.00M 10-K · filed 2026-02-23 | |
| 2024-12-31 | $207.00M 10-K · filed 2026-02-23 | |
| 2023-12-31 | $192.00M 10-K · filed 2026-02-23 | |
| 2022-12-31 | $190.00M 10-K · filed 2025-02-21 | |
| 2021-12-31 | $186.00M 10-K · filed 2024-02-23 | |
| 2020-12-31 | $185.00M 10-K · filed 2023-02-24 | |
| 2019-12-31 | $190.00M 10-K · filed 2022-02-25 | $209.00M 10-K · filed 2020-02-28 |
| 2018-12-31 | $193.00M 10-K · filed 2021-02-26 | $216.00M 10-K · filed 2019-03-01 |
| 2017-12-31 | $177.00M 8-K · filed 2020-09-25 | $201.00M 10-K · filed 2018-02-23 |
| 2016-12-31 | $189.00M 10-K · filed 2019-03-01 | |
| 2015-12-31 | $191.00M 10-K · filed 2018-02-23 | |
| 2014-12-31 | $197.00M 10-K · filed 2017-02-24 | |
| 2013-12-31 | $188.00M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $183.00M 10-K · filed 2015-02-27 | |
| 2011-12-31 | $96.00M 10-K · filed 2014-02-28 | |
| 2010-12-31 | $88.00M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $86.00M 10-K · filed 2012-02-28 | |
| 2008-12-31 | $86.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |